Revolution Medicines discovers and develops new medicines for cancer patients, with a focus on frontier oncology targets.

We combine deep chemical biology and cancer pharmacology know-how with sophisticated structure-based drug discovery capabilities and astute precision medicine approaches to develop novel targeted therapies.

Read more

We are developing novel targeted therapies to inhibit elusive frontier oncology targets within notorious growth and survival pathways, with a particular emphasis on the RAS and mTOR signaling pathways.

Read more

We are pursuing both combination and monotherapy precision medicine development strategies for our programs to allow us to target specific oncogenic mutations and combat adaptive resistance.

Read more